PRICE T ROWE ASSOCIATES INC /MD/ - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$14,000
-33.3%
18,2000.0%0.00%
Q2 2022$21,000
-43.2%
18,2000.0%0.00%
Q1 2022$37,000
-28.8%
18,2000.0%0.00%
Q4 2021$52,000
-32.5%
18,2000.0%0.00%
Q3 2021$77,000
-38.4%
18,200
-22.9%
0.00%
Q2 2021$125,000
-12.0%
23,600
-22.6%
0.00%
Q1 2021$142,000
+40.6%
30,5000.0%0.00%
Q4 2020$101,000
-76.3%
30,500
-76.4%
0.00%
Q3 2020$427,000
-1.8%
129,0000.0%0.00%
Q2 2020$435,000
+2.4%
129,000
+16.2%
0.00%
Q1 2020$425,000
+1.0%
111,048
+59.2%
0.00%
Q4 2019$421,000
+194.4%
69,748
+269.1%
0.00%
Q3 2019$143,000
-73.8%
18,898
-53.0%
0.00%
Q2 2019$545,000
-9.9%
40,192
-64.0%
0.00%
Q1 2019$605,000
+395.9%
111,600
+170.9%
0.00%
Q4 2018$122,000
-79.1%
41,200
-42.5%
0.00%
Q3 2018$584,000
+3.0%
71,600
+23.0%
0.00%
Q2 2018$567,000
+56.6%
58,200
+39.7%
0.00%
Q1 2018$362,000
-30.5%
41,655
+0.1%
0.00%
Q4 2017$521,00041,6320.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 2,679,457$20,257,0000.73%
Portolan Capital Management 777,293$5,876,0000.66%
CAMPBELL CAPITAL MANAGEMENT INC 110,451$835,0000.62%
ZEKE CAPITAL ADVISORS, LLC 402,212$3,041,0000.27%
Leap Investments LP 46,084$348,0000.17%
Bernardo Wealth Planning LLC 26,419$199,0000.14%
Claraphi Advisory Network, LLC 14,744$111,0000.07%
Sterling Investment Advisors, Ltd. 11,000$83,0000.04%
A.R.T. Advisors, LLC 81,372$615,0000.03%
Mirae Asset Global Investments Co., Ltd. 544,408$4,116,0000.03%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders